NCT01468623: Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 |
|
|
| Terminated | 4 | 51 | US | Pharmacokinetic 5-FU dose adjustment using OnDoseĀ® assay, OnDoseĀ®, Standard of care | Myriad Genetic Laboratories, Inc. | Colorectal Cancer, Metastatic | 08/12 | 08/12 | | |
ASCENT, NCT01588990: A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer |
|
|
| Completed | 4 | 128 | RoW | Oxaliplatin, Capecitabine, Bevacizumab, Avastin, RO4876646, Leucovorin, 5-Fluouracil, Irinotecan | Hoffmann-La Roche | Colorectal Neoplasms | 09/16 | 09/16 | | |